NLRP3 and metabolic dysfunction-associated steatotic liver disease: Recently, Li et al. Found that MALAT1 may regulate liver inflammation by activating NLRP3 inflammatory complex in chronic hepatitis B with nonalcoholic fatty liver disease (Li et al., 2021).